INTRODUCTION AND OBJECTIVES: Up to now, for renal cell carcinoma (RCC), tumor size and growth rate are the most used prognostic factors at diagnosis likely being related with potential progressive neoplasms. Moreover, the degree of the free tumor extension into renal vessel seems to contribute to disease-free survival and to influence prognosis. Thus, firstly, in order to highlight urinary peptidome signatures that might reflect kidney cancer progression, a systematic investigation by MALDI profiling was carried out identifying endogenous peptides that show a correlation between their abundance in urine and pT, tumor size and grade. Secondly, in order to explore proteome changes reflecting the local tumor infiltration through vena...
OBJECTIVES: To review urinary protein biomarkers as potential non-invasive, easily obtainable, early...
Renal cancer has many clinical challenges which proteomics is ideally placed to address. The issues ...
Renal cell carcinoma (RCC) is the most deadly of urological malignancies. Metastatic disease affects...
INTRODUCTION AND OBJECTIVES: Up to now, for renal cell carcinoma (RCC), tumor size and growth rate ...
Background: Several promising biomarkers have been found for RCC, but none of them has been used in ...
Background: Several promising biomarkers have been found for RCC, but none of them has been used in ...
Renal Cell Carcinoma (RCC) is typically asymptomatic and surgery usually increases patient's lifespa...
Introduction & Objectives: Renal cell cancer (RCC) substantially lacks of biomarkers to assist clin...
<div><p>Renal Cell Carcinoma (RCC) is typically asymptomatic and surgery usually increases patient's...
Renal Cell Carcinoma (RCC) is typically asymptomatic and surgery usually increases patient's lifespa...
BackgroundRenal cell carcinoma (RCC) is the sixth leading cause of cancer death and is responsible f...
Cancer is one of the main causes of death worldwide, contributing to 21% of the overall mortality ra...
Renal cell carcinoma (RCC) is the most deadly of urological malignancies. Metastatic disease affects...
In recent years molecular biologists and pathologists have described new entities of renal cell canc...
Worldwide, over 273,000 people are diagnosed with renal cancer each year. Approximately one third of...
OBJECTIVES: To review urinary protein biomarkers as potential non-invasive, easily obtainable, early...
Renal cancer has many clinical challenges which proteomics is ideally placed to address. The issues ...
Renal cell carcinoma (RCC) is the most deadly of urological malignancies. Metastatic disease affects...
INTRODUCTION AND OBJECTIVES: Up to now, for renal cell carcinoma (RCC), tumor size and growth rate ...
Background: Several promising biomarkers have been found for RCC, but none of them has been used in ...
Background: Several promising biomarkers have been found for RCC, but none of them has been used in ...
Renal Cell Carcinoma (RCC) is typically asymptomatic and surgery usually increases patient's lifespa...
Introduction & Objectives: Renal cell cancer (RCC) substantially lacks of biomarkers to assist clin...
<div><p>Renal Cell Carcinoma (RCC) is typically asymptomatic and surgery usually increases patient's...
Renal Cell Carcinoma (RCC) is typically asymptomatic and surgery usually increases patient's lifespa...
BackgroundRenal cell carcinoma (RCC) is the sixth leading cause of cancer death and is responsible f...
Cancer is one of the main causes of death worldwide, contributing to 21% of the overall mortality ra...
Renal cell carcinoma (RCC) is the most deadly of urological malignancies. Metastatic disease affects...
In recent years molecular biologists and pathologists have described new entities of renal cell canc...
Worldwide, over 273,000 people are diagnosed with renal cancer each year. Approximately one third of...
OBJECTIVES: To review urinary protein biomarkers as potential non-invasive, easily obtainable, early...
Renal cancer has many clinical challenges which proteomics is ideally placed to address. The issues ...
Renal cell carcinoma (RCC) is the most deadly of urological malignancies. Metastatic disease affects...